<DOC>
	<DOCNO>NCT01765179</DOCNO>
	<brief_summary>The purpose study determine oral testosterone undecanoate effective safe treatment low testosterone men .</brief_summary>
	<brief_title>Safety Efficacy Trial Testosterone Undecanoate</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Eunuchism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Serum testosterone less equal 300 ng/dL ( mean two sample collect 1 hour apart morning 6:00 10:00 AM ) Significant intercurrent disease type , particular liver , kidney , uncontrolled poorly control heart disease include hypertension , CHF CAD , psychiatric illness include depression . Recent history stroke , include transient ischemic attack ( TIA ) acute coronary event Untreated , severe obstructive sleep apnea Hematocrit &lt; 35 % &gt; 48 % Serum transaminases &gt; 2 time upper limit normal , serum bilirubin &gt; 2.0 mg/dL , serum creatinine &gt; 2.0 mg/dL BMI &gt; equal 38 Stable dos lipidlowering medication less three month Stable dos oral medication diabetes less two month Abnormal prostate digital rectal examination [ palpable nodule ( ) ] , elevate PSA ( serum PSA &gt; 3.9 ng/mL ) , IPSS score &gt; equal 19 point , /or history prostate cancer . History breast cancer Use dietary supplement saw palmetto phytoestrogens use dietary supplement may increase serum T , androstenedione DHEA previous 4 week Know malabsorption syndrome and/or current treatment iwht oral lipase inhibitor Known history abuse alcohol drug substance previous 2 year Current use antiandrogens , estrogen , oral CYP3A4 inducer inhibitor , longacting opioid analgesic Receipt drug part research study within 30 day initial dose administration study Blood donation within 12 week period initial dose administration study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>testosterone</keyword>
	<keyword>male hypogonadism</keyword>
	<keyword>low testosterone</keyword>
</DOC>